ESR1 and triple-negative breast carcinoma: The triple negative breast cancer cell lines (Sum149 and HCC1937), which are negative for estrogen receptors, progesterone receptors, and HER218, also showed a significant loss of viability after treatment with TAK-165 and AC220 (Fig. 2c).